Skip to main content
    M

    Mereo BioPharma Group PLC ADR (MREO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.27
    -0.03 (-10.00%)

    Market Cap: $48.71M

    Last updated: Nov 17, 2026 at 4:36 PM ET

    Mereo BioPharma Group PLC ADR (MREO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Mereo BioPharma Group PLC ADR (MREO) has a latest price of $0.27 on Nov 17, 2026, 88.4% below its 52-week high of $2.37. Its price fell 84.6% over the past 12 months. The month-end price fell 87.1% over the 5 years through Oct 2026, a compound annual decline of 33.6%.

    Price Chart

    From Apr 2019 to Oct 2026, its highest month-end close was $5.60 in Apr 2019 and its lowest $0.27 in Aug 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MREO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MREO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 11.9%, and over 6 months it rose 15.3%. The month-end price fell 85.6% over the 3 years through Oct 2026, a compound annual decline of 47.5%.

    PeriodChange
    1 month-9.1%
    3 months-11.9%
    6 months+15.3%
    12 months-84.6%
    12 months, with dividends-84.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-85.6%-47.5%
    5 years-87.1%-33.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 208.0%, and its weakest was 2025, when it fell 88.1%.

    YearCloseChange
    2026 through Oct 2026$0.29-30.5%
    2025$0.42-88.1%
    2024$3.50+51.5%
    2023$2.31+208.0%
    2022$0.75-53.1%
    2021$1.60-55.3%
    2020$3.58+9.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 11.8% below its 50-day average of $0.31 and 14.2% below its 200-day average of $0.32.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.27
    52-week high$2.37-88.4%
    52-week low$0.20+37.3%
    50-day average$0.31-11.8%
    200-day average$0.32-14.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 95.1%.

    MeasureValue
    1-year beta1.70
    Largest fall, 1 year-89.7%
    Largest fall, 3 years-95.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MREO

    What is MREO's 1-year price change?

    Mereo BioPharma Group PLC ADR's price fell 84.6% over the past 12 months. With dividends included, the 12-month total return was -84.6%.

    What is MREO's 5-year price change?

    Mereo BioPharma Group PLC ADR's month-end price fell 87.1% over the 5 years through Oct 2026, a compound annual decline of 33.6%. These figures leave out dividends.

    What is MREO's 52-week high and low?

    Mereo BioPharma Group PLC ADR's 52-week high is $2.37 and its 52-week low is $0.20. Its latest price of $0.27 on Nov 17, 2026 is 88.4% below the high.

    What is MREO's beta?

    Mereo BioPharma Group PLC ADR's 1-year beta against the S&P 500 is 1.70, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 89.7%.

    Is the MREO chart free?

    Yes. Advanced Charting for MREO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.